A nurse treats a pediatric patient using vein illumination technology VeinViewer Vision2 (PRNewsFoto/Christie Medical Holdings, Inc.)
Mobile vascular imaging device VeinViewer Vision2 aids nurses pre-, during and post-access (PRNewsFoto/Christie Medical Holdings, Inc.)
August 21, 2014 — Christie Medical Holdings and Wolfson Children’s Hospital announced an agreement to replace all current peripheral vascular access visualization devices at the hospital with 17 VeinViewers through Christie's FreshStart program. The hospital was using the latest version of a hand-held, red laser-based competitive illumination device, but switched to Christie's VeinViewer, which can provide pre-, during and post-access benefits throughout the entire vascular access procedure and has been shown through clinical studies to increase both first stick success and patient satisfaction up to 100 percent while reducing medically unnecessary PICC lines by more than 30 percent.
"It is extremely important to the administration of Wolfson Children's Hospital to provide the nursing staff with the best tools for performing IV starts on children," said Veronica Scott-Fulton, vice president, operations and patient care services, Wolfson Children's Hospital. "We believe that the technology and support provided by Christie Medical are the best available and will result in fewer sticks and improved patient and family satisfaction. We are pleased to partner with Christie Medical to make Wolfson Children's a vascular access center of excellence."
Holly Hess of Wolfson Children's Hospital added, "In my experience as a pediatric vascular access clinician, I have the opportunity to use various types of vein visualization devices. I find the Christie VeinViewer products to have a clearly superior, crisp image that shows peripheral vasculature in a way that enhances the practitioner's ability to find and access veins."
"Our FreshStart program provides a significant financial benefit to all medical facilities who want to replace their unsatisfactory vein illumination devices with the VeinViewer solution. The proven results of our technology backed by our revolutionary Christie Assure Program, provides a solution that is trusted to deliver results year after year," said Chris Schnee, general manager and vice president of sales and marketing at Christie Medical Holdings.
The Christie Assure program is a comprehensive set of services including a five-year utilization training program, five-year warranty, five-year clinical education provision for hospital medical staff and five-year upgrade program to the latest product platforms from Christie.
VeinViewer technology was developed with the aid of parent company Christie Digital Systems. VeinViewer is the first and only device on the market to use: harmless near-infrared light, DLP technologies, exclusive technology such as Active Vascular Imaging Navigation (AVIN) providing the demanded Pre-, During and Post-Access (PDP) benefits, TrueView imaging accuracy in projected vein widths and technologies such as Df2 (Digital Full Field) to illuminate the only real-time HD digital image of subcutaneous vasculature and blood patterns directly onto the skin surface. Although designed for assistance in IV starts and blood draws, VeinViewer has proven beneficial in spider and varicose vein treatment.
For more information: www.christiemed.com
